Histogen Inc.
HSTODelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001383701
Histogen Inc. was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Jun 21, 2023; 9 institutions reported holding it in 13F filings for Q3 2023, worth $9.53K in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Histogen Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 9 | 1 | −8 |
| Shares | 18.5K | 17 | −18.5K (−99.9%) |
| Value | $9.53K | $5 | −$9.52K (−99.9%) |
New holders (0)
Institutions that held Histogen Inc. at the end of Q4 2023 but not at the end of Q3 2023.
None.
Sold out (8)
Institutions that held Histogen Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Synovus Financial Corp | 10,050 | $5.17K |
| Morgan Stanley | 8,000 | $4.12K |
| Advisor Group Holdings, Inc. | 275 | $142 |
| UBS Group AG | 89 | $46 |
| Wells Fargo & Company | 62 | $32 |
| Global Retirement Partners, LLC | 15 | $10 |
| Compagnie Lombard Odier SCmA | 15 | $8 |
| Royal Bank of Canada | 15 | $0 |